Tirzepatide Rules The Day On Lilly Earnings Call

Robust Sales In Diabetes And Obesity, Plus Good Data In NASH

 
• By Joseph Haas
Lilly office building
Lilly reports soaring sales for Mounjaro and Zepbound • Source: Shutterstock

More from Earnings

More from Business